Home
/
Treatment
/
2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt

2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt

	2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt
Trade Name
Orphan Indication	Hepatocellular Carcinoma
USA Market Approval	USA
USA Designation Date	2014-07-01 00:00:00
Sponsor	CASI Pharmaceuticals, Inc.;9620 Medical Center Drive, Suite 300;Rockville, Maryland, 20850

Related Access Program